全文获取类型
收费全文 | 192504篇 |
免费 | 2047篇 |
国内免费 | 51篇 |
专业分类
耳鼻咽喉 | 1272篇 |
儿科学 | 7075篇 |
妇产科学 | 3361篇 |
基础医学 | 18830篇 |
口腔科学 | 2159篇 |
临床医学 | 13520篇 |
内科学 | 35308篇 |
皮肤病学 | 1116篇 |
神经病学 | 17895篇 |
特种医学 | 9273篇 |
外科学 | 31205篇 |
综合类 | 2418篇 |
一般理论 | 8篇 |
预防医学 | 19262篇 |
眼科学 | 3354篇 |
药学 | 10288篇 |
中国医学 | 693篇 |
肿瘤学 | 17565篇 |
出版年
2023年 | 137篇 |
2022年 | 228篇 |
2021年 | 658篇 |
2020年 | 363篇 |
2019年 | 529篇 |
2018年 | 22460篇 |
2017年 | 17669篇 |
2016年 | 19848篇 |
2015年 | 1424篇 |
2014年 | 1426篇 |
2013年 | 1609篇 |
2012年 | 8296篇 |
2011年 | 22388篇 |
2010年 | 19534篇 |
2009年 | 12214篇 |
2008年 | 20702篇 |
2007年 | 22910篇 |
2006年 | 1785篇 |
2005年 | 3270篇 |
2004年 | 4303篇 |
2003年 | 5238篇 |
2002年 | 3315篇 |
2001年 | 395篇 |
2000年 | 504篇 |
1999年 | 298篇 |
1998年 | 333篇 |
1997年 | 311篇 |
1996年 | 192篇 |
1995年 | 197篇 |
1994年 | 194篇 |
1993年 | 136篇 |
1992年 | 83篇 |
1991年 | 132篇 |
1990年 | 160篇 |
1989年 | 111篇 |
1988年 | 83篇 |
1987年 | 74篇 |
1986年 | 50篇 |
1985年 | 59篇 |
1984年 | 61篇 |
1983年 | 54篇 |
1982年 | 60篇 |
1981年 | 51篇 |
1980年 | 62篇 |
1978年 | 40篇 |
1976年 | 37篇 |
1969年 | 37篇 |
1938年 | 60篇 |
1932年 | 56篇 |
1930年 | 46篇 |
排序方式: 共有10000条查询结果,搜索用时 140 毫秒
991.
Dolores Caballero Jose A García-Marco Rodrigo Martino Victoria Mateos José M Ribera José Sarrá Angel León Guillermo Sanz Javier de la Serna Rafael Cabrera Marcos González Jorge Sierra Jesús San Miguel 《Clinical cancer research》2005,11(21):7757-7763
PURPOSE: To evaluate the efficacy of reduced intensity conditioning (RIC) allogeneic transplant in 30 patients with poor-prognosis chronic lymphocytic leukemia (CLL) and/or high-risk molecular/cytogenetic characteristics. EXPERIMENTAL DESIGN: Eighty-three percent of patients had active disease at the moment of transplant. That is, 14 of the 23 patients analyzed (60%) had unmutated immunoglobulin variable heavy-chain gene (IgV(H)) status; 8 of 25 patients (32%) had 11q-, with four of them also displaying unmutated IgV(H); and six (24%) had 17p- (five were also unmutated). RESULTS: After a median follow-up of 47.3 months, all 22 patients alive are disease free; overall survival and event-free survival (EFS) at 6 years were 70% and 72%, respectively. According to molecular/cytogenetic characteristics, overall survival and EFS for unmutated CLL and/or with 11q- aberration (n = 13) were 90% and 92%, respectively, not significantly different to those with normal in situ hybridization, 13q- and +12, or mutated CLL (n = 7). All six patients with 17p deletion were transplanted with active disease, including three with refractory disease; all except one reached complete remission after the transplant and two are alive and disease free. Nonrelapse mortality (NRM) was 20%; more than two lines before transplant is an independent prognostic factor for NRM (P = 0,02), EFS (P = 0.02), and overall survival (P = 0.01). Patients older than 55 years have a higher risk of NRM (hazard ratio, 12.8; 95% confidence interval, 1.5-111). Minimal residual disease was monitored by multiparametric flow cytometry in 21 patients. Clearance of CD79/CD5/CD19/CD23 cells in bone marrow was achieved in 68% and 94% of the patients at days 100 and 360, respectively. CONCLUSION: According to these results, RIC allogeneic transplant could overcome the adverse prognosis of patients with unmutated CLL as well as those with 11q- or 17p-. 相似文献
992.
Francis Giles Srdan Verstovsek Deborah Thomas Stanton Gerson Jorge Cortes Stefan Faderl Alessandra Ferrajoli Farhad Ravandi Steven Kornblau Guillermo Garcia-Manero Elias Jabbour Susan O'Brien Verena Karsten Ann Cahill Karen Yee Maher Albitar Mario Sznol Hagop Kantarjian 《Clinical cancer research》2005,11(21):7817-7824
PURPOSE: Cloretazine (VNP40101M) is a novel sulfonylhydrazine alkylating agent with significant antileukemia activity. A phase I study of cloretazine combined with cytarabine (1-beta-d-arabinofuranosylcytosine, ara-C) was conducted in patients with refractory disease. DESIGN: Ara-C was given i.v. at a fixed dose of 1.5 gm/m(2)/d by continuous infusion for 4 days (patients ages <65 years at time of diagnosis) or 3 days (patients ages > or =65 years). Cloretazine was given i.v. over 15 to 60 minutes on day 2 at a starting dose of 200 mg/m(2), with escalation in 100 mg/m(2) increments in cohorts of three to six patients until a maximum tolerated dose was established. The DNA repair enzyme O(6)-alkylguanine DNA alkyltransferase (AGT) was measured at baseline. RESULTS: Forty patients, including 32 with acute myeloid leukemia, received 47 courses of treatment. Complete responses were seen at cloretazine dose levels of > or =400 mg/m(2) in 10 of 37 (27%) evaluable patients, and in this patient subset, AGT activity was significantly lower in patients that responded to treatment than in patients who did not (P < or = 0.027). Dose-limiting toxicities (gastrointestinal and myelosuppression) were seen with 500 and 600 mg/m(2) of cloretazine combined with the 4-day ara-C schedule but not seen with the 3-day schedule. CONCLUSION: The recommended cloretazine dose schedule for future studies is 600 mg/m(2) combined with 1.5 gm/m(2)/d continuous infusion of ara-C for 3 days. The cloretazine and ara-C regimen has significant antileukemic activity. AGT activity may be a predictor of response to cloretazine. 相似文献
993.
994.
995.
996.
997.
998.
Jorge I González Borroto Giselle Pérez Amadeu Creus Ricard Marcos 《Food and chemical toxicology》2004,42(2):187-193
The genotoxic potential of the compound 1-(5-bromofur-2-yl)-2-bromo-2-nitroethene (G-1) was evaluated in peripheral blood lymphocytes cultured in vitro, at concentrations ranging from 1 to 20 microg/ml. Micronuclei (MN) and sister-chromatid exchanges (SCE) were scored as biomarkers of genotoxic effects. To detect the role of metabolic enzymes on the genotoxicity of this furylethylenic derivative, cultures for MN and SCE demonstrations were treated for 3 h with and without the S9 microsomal fraction as well as for 48 h without S9. Under the conditions of the study, the test agent did not induce significant increases in the frequency of micronucleated cells, irrespective of the presence/absence of the metabolic fraction. Nevertheless, a slight/moderate increase in the SCE frequency was observed in those cultures treated without the S9 mix. In addition, cytotoxic/cytostatic effects of the G-1 compound were observed mainly in cultures without S9 fraction, as indicated by the reduction of cell proliferation measured by the cytokinesis block proliferation index (CBPI) and the proliferative rate index (PRI). 相似文献
999.
Most cited papers in Toxicon. 总被引:2,自引:0,他引:2
Citation of a published work is one of the parameters considered in the analysis of relevance and importance of scientific contributions. In 2002, for the first time the Impact Factor of Toxicon has risen above 2.0, placing it at the 17th position among 76 journals in the 'toxicology' field. The aim of this article was to identify the most cited articles in Toxicon, that have contributed to the steady increase of its Impact Factor. The number of citations, complete reference and type of all documents appearing in Toxicon in the period 1963-2003 were retrieved from the ISI Web-of-Science homepage. The documents retrieved were sorted by the number of citations received. A 'citation index', defined as the number of citations divided by the number of years since publication, was calculated for each document. It was clearly seen that reviews in Toxicon received 4.4-fold more citations than articles. Unexpectedly, it was found that recent papers were proportionally more cited than old ones. A decrease in the proportion of papers dealing on 'snake*' through out the period and the broadened range of subjects of the most cited papers recently published in Toxicon reflects an increased 'visibility' in other fields of toxinology. Research on plant toxins gained its own space in Toxicon with newer publications showing high citation indexes. It can be postulated that these facts helped to increase Toxicon's Impact Factor from 1.248 in 1999 to 2.003 in 2002. With the increased number of issues in Toxicon as well as publications of subject-dedicated volumes containing mostly reviews, the Impact Factor of Toxicon is expected to keep rising in the near future. 相似文献
1000.
Blanca Ramos-Cerrillo Alejandro Olvera George V Odell Fernando Zamudio Jorge Paniagua-Solís Alejandro Alagón Roberto P Stock 《Toxicon》2004,44(5):507-514
In this study we report the isolation and characterization of several sphingomyelinase D isoforms from the venoms of the North American spiders Loxosceles boneti and Loxosceles reclusa, from Mexico and the United States, respectively. We have measured their enzymatic activity, their capacity to induce necrotic lesions in rabbits, cloned the cDNAs coding for the mature forms of two of the isoforms from L. boneti and two of L. reclusa based on N-terminal sequence information of the purified proteins, and performed a comprehensive comparison of the sequence data generated by us with that reported for other sphingomyelinase genes to date. 相似文献